Principles and analytical performance of Abbott RealTime High Risk HPV test
Authors:
- Shihai HuangSHShihai Huang
- Ning TangNTNing Tang
- Wai-Bing MakWMWai-Bing Mak
- Brian EricksonBEBrian Erickson
- John SalituroJSJohn Salituro
- Yuhong LiYLYuhong Li
- Evelyn KrumpeEKEvelyn Krumpe
- George SchneiderGSGeorge Schneider
- Hong YuHYHong Yu
- John RobinsonJRJohn Robinson
- Klara AbravayaKAKlara Abravaya
- 1 July 2009
- journal article
- research article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 45, S13-S17
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- High-risk HPV detection and concurrent HPV 16 and 18 typing with Abbott RealTime High Risk HPV testJournal of Clinical Virology, 2009
- Clinical performance of Abbott RealTime High Risk HPV test for detection of high-grade cervical intraepithelial neoplasia in women with abnormal cytologyJournal of Clinical Virology, 2009
- Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and olderInternational Journal of Cancer, 2008
- Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing CountriesVaccine, 2008
- A new method for robust quantitative and qualitative analysis of real-time PCRNucleic Acids Research, 2008
- Monitoring HPV vaccinationVaccine, 2008
- Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis updateInternational Journal of Cancer, 2007
- HPV Detection MethodsDisease Markers, 2007
- Clinical utility of HPV genotypingGynecologic Oncology, 2006
- The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical PracticeJNCI: Journal of the National Cancer Institute, 2005